1. Serum Insulin-Like Growth Factor-II and α-Fetoprotein as Tumor Markers of Hepatocellular Carcinoma
- Author
-
Minnie Ho, S.C. Chen, Jen-Eing Jeng, Wan-Lung Chuang, Zu-Yau Lin, Chiung-Ru Lai, H.L. You, Chia-Yen Dai, Lea-Yea Chuang, Linda Wang, J.-F. Tsai, Min-Yuh Hsieh, and M.-L. Yu
- Subjects
Adult ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Cirrhosis ,medicine.medical_treatment ,Serum insulin ,Insulin-like growth factor ,Insulin-Like Growth Factor II ,Risk Factors ,Internal medicine ,Biomarkers, Tumor ,medicine ,Humans ,neoplasms ,Aged ,Insulin-like growth factor-II ,Tumor marker ,business.industry ,Growth factor ,Liver Neoplasms ,digestive, oral, and skin physiology ,General Medicine ,Middle Aged ,medicine.disease ,digestive system diseases ,Endocrinology ,ROC Curve ,Hepatocellular carcinoma ,embryonic structures ,Female ,alpha-Fetoproteins ,Oncofetal antigen ,business - Abstract
To evaluate the diagnostic application of serum insulin-like growth factor-II (IGF-II) and alpha-fetoprotein (AFP) levels in hepatocellular carcinoma (HCC), IGF-II and AFP were determined in 100 cirrhotic patients with HCC, 100 sex- and age-matched patients with cirrhosis alone and 50 healthy controls. The results indicated that IGF-II and AFP levels in patients with HCC were higher than in those with cirrhosis alone (p = 0.0001). There is an inverse correlation between IGF-II and (log)AFP (r = -0.410, p = 0.0001) in patients with HCC. Multivariate analysis indicated that IGF-II and AFP were closely associated, in a dose-related fashion, with the presence of HCC. Receiver operating characteristic curves were used to determine the optimal cutoff values of IGF-II (4.5 mg/g prealbumin) and AFP (100 ng/ml), respectively. Both IGF-II and AFP show a high specificity and positive likelihood ratio. The sensitivity was 42.0% for IGF-II and 73.0% for AFP. Determination of both markers in parallel significantly increased the diagnostic accuracy (96.5%) and sensitivity (97.9%), with a high specificity (95.1%) and positive likelihood ratio (19.9). In conclusion, IGF-II and AFP may be used as complementary tumor markers to discriminate HCC from cirrhosis.
- Published
- 2003
- Full Text
- View/download PDF